Skip to main content
Top
Published in: Journal of Urban Health 4/2010

Open Access 01-07-2010

Access to Sterile Syringes through San Francisco Pharmacies and the Association with HIV Risk Behavior among Injection Drug Users

Authors: Elise D. Riley, Alex H. Kral, Thomas J. Stopka, Richard S. Garfein, Paul Reuckhaus, Ricky N. Bluthenthal

Published in: Journal of Urban Health | Issue 4/2010

Login to get access

Abstract

Increased options for syringe acquisition and disposal have been associated with reductions in high-risk behaviors. This study determined the extent of pharmacy uptake in accessing syringes among injection drug users (IDUs) and estimated associations between pharmacy uptake and safer injection/disposal practices. Two years after the implementation of California’s Disease Prevention Demonstration Project, which removed restrictions to non-prescription syringe sales through pharmacies with local authorization, IDUs were recruited through street outreach in San Francisco and interviewed regarding recent syringe acquisition, use, and disposal. The sample of 105 persons included a high proportion of men (67%), people of color (49%), and homeless persons (71%). The most common syringe source was a syringe exchange program (SEP) (80%), with pharmacies being accessed by 39% of respondents. The most commonly cited source of disposal was a SEP (65%), with very few reports of pharmacy disposal (2%). Adjusted analysis showed that unsuccessful attempts to purchase syringes at a pharmacy increased the odds of both injecting with a used syringe and giving away a used syringe. Using a SEP decreased the odds of unsafe injection and disposal practices. Thus, 2 years after the initiation of the California Disease Prevention Demonstration Project, results from this small study suggest that SEPs still provide the majority of syringe distribution and disposal services to San Francisco IDUs; however, pharmacies now augment syringe access. In addition, unsafe injection behavior is reported more often among those who do not use these syringe sources. These results are consistent with prior studies in suggesting that increasing the availability of syringes through SEPs and pharmacies, and developing bridges between them, may further reduce syringe-related risk.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Update: syringe exchange programs—United States, 2002. MMWR Morb Mortal Wkly Rep. 2005; 54(27): 673–676. Centers for Disease Control and Prevention. Update: syringe exchange programs—United States, 2002. MMWR Morb Mortal Wkly Rep. 2005; 54(27): 673–676.
2.
go back to reference Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS Public Policy J. 2000; 15(3–4): 88–94.PubMed Khoshnood K, Blankenship KM, Pollack HA, Roan CT, Altice FL. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut. AIDS Public Policy J. 2000; 15(3–4): 88–94.PubMed
3.
go back to reference Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004; 99(9): 1136–1146.CrossRefPubMed Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004; 99(9): 1136–1146.CrossRefPubMed
4.
go back to reference Rich JD, Wolf FA, Macalino G. Strategies to improve access to sterile syringes for injection drug users. AIDS Read. 2002; 12(12): 527–535.PubMed Rich JD, Wolf FA, Macalino G. Strategies to improve access to sterile syringes for injection drug users. AIDS Read. 2002; 12(12): 527–535.PubMed
5.
go back to reference Riley E, Beilenson P, Vlahov D, et al. Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J Acquir Immune Defic Syndr Human Retrovirol. 1998; 18(Suppl 1): S120–S125. Riley E, Beilenson P, Vlahov D, et al. Operation Red Box: a pilot project of needle and syringe drop boxes for injection drug users in East Baltimore. J Acquir Immune Defic Syndr Human Retrovirol. 1998; 18(Suppl 1): S120–S125.
6.
go back to reference Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. Aids. 2000; 14(5): 605–611.CrossRefPubMed Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. Aids. 2000; 14(5): 605–611.CrossRefPubMed
7.
go back to reference MacDonald M, Law M, Kaldor J, Hales J, Dore G. Effectiveness of needle and syringe programs for preventing HIV transmission. International Journal of Drug Policy. 2003; 14(5/6): 353–357.CrossRef MacDonald M, Law M, Kaldor J, Hales J, Dore G. Effectiveness of needle and syringe programs for preventing HIV transmission. International Journal of Drug Policy. 2003; 14(5/6): 353–357.CrossRef
8.
go back to reference Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997; 349(9068): 1797–1800.CrossRefPubMed Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997; 349(9068): 1797–1800.CrossRefPubMed
9.
go back to reference Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005; 95(8): 1439–1444.CrossRefPubMed Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005; 95(8): 1439–1444.CrossRefPubMed
10.
go back to reference Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471–477.CrossRefPubMed Pouget ER, Deren S, Fuller CM, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39(4): 471–477.CrossRefPubMed
11.
go back to reference Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91(5): 791–793.CrossRefPubMed Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91(5): 791–793.CrossRefPubMed
12.
go back to reference Pollini RA, Lozada R, Gallardo M, et al. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study. AIDS Behav. 2010;14(3):679–87.CrossRefPubMed Pollini RA, Lozada R, Gallardo M, et al. Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study. AIDS Behav. 2010;14(3):679–87.CrossRefPubMed
13.
go back to reference Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S68–S72.CrossRef Reich W, Compton WM, Horton JC, et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S68–S72.CrossRef
14.
go back to reference Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117–124.CrossRefPubMed Fuller CM, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97(1): 117–124.CrossRefPubMed
15.
go back to reference Cleland CM, Deren S, Fuller CM, et al. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007; 34(2): 390–403.CrossRefPubMed Cleland CM, Deren S, Fuller CM, et al. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Health Educ Behav. 2007; 34(2): 390–403.CrossRefPubMed
16.
go back to reference Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J Acquir Immune Defic Syndr. 2001; 27(2): 183–192.PubMed Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G. Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. J Acquir Immune Defic Syndr. 2001; 27(2): 183–192.PubMed
17.
go back to reference Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.CrossRefPubMed Stopka TJ, Garfein RS, Ross A, Truax SR. Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel. J Urban Health. 2007; 84(1): 116–125.CrossRefPubMed
18.
go back to reference Garfein R, Stopka T, Pavlinac P, Haye K, Riley E, Bluthenthal R. Three years into legalization of over-the-counter (OTC) syringe sales in California (SB1159): where are we now? Journal of Urban Health; 87(4). doi:10.1007/s11524-010-9463-3. Garfein R, Stopka T, Pavlinac P, Haye K, Riley E, Bluthenthal R. Three years into legalization of over-the-counter (OTC) syringe sales in California (SB1159): where are we now? Journal of Urban Health; 87(4). doi:10.​1007/​s11524-010-9463-3.
19.
20.
21.
go back to reference Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81–89.PubMed Singer M, Baer HA, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998; 113(Suppl 1): 81–89.PubMed
22.
go back to reference Birkhead GS, Klein SJ, Candelas AR, et al. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy. 2007; 18(5): 417–425.CrossRefPubMed Birkhead GS, Klein SJ, Candelas AR, et al. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy. 2007; 18(5): 417–425.CrossRefPubMed
23.
go back to reference Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S73–S76. Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001. J Am Pharm Assoc (Wash). 2002; 42(6 Suppl 2): S73–S76.
24.
go back to reference HIV prevention and access to sterile syringes. Joint letter issued by the American Medical Association, American Pharmaceutical Association, Association of State and Territorial Health Officials, National Association of Boards of Pharmacy, National Alliance of State and Territorial AIDS Directors: National Alliance of State and Territorial AIDS Directors; 1999. HIV prevention and access to sterile syringes. Joint letter issued by the American Medical Association, American Pharmaceutical Association, Association of State and Territorial Health Officials, National Association of Boards of Pharmacy, National Alliance of State and Territorial AIDS Directors: National Alliance of State and Territorial AIDS Directors; 1999.
25.
go back to reference Weinstein B, Toce P, Katz D, Ryan LL. Peer education of pharmacists and supplying pharmacies with IDU packets to increase injection drug users’ access to sterile syringes in Connecticut. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S146–S147.PubMed Weinstein B, Toce P, Katz D, Ryan LL. Peer education of pharmacists and supplying pharmacies with IDU packets to increase injection drug users’ access to sterile syringes in Connecticut. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(Suppl 1): S146–S147.PubMed
Metadata
Title
Access to Sterile Syringes through San Francisco Pharmacies and the Association with HIV Risk Behavior among Injection Drug Users
Authors
Elise D. Riley
Alex H. Kral
Thomas J. Stopka
Richard S. Garfein
Paul Reuckhaus
Ricky N. Bluthenthal
Publication date
01-07-2010
Publisher
Springer US
Published in
Journal of Urban Health / Issue 4/2010
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-010-9468-y

Other articles of this Issue 4/2010

Journal of Urban Health 4/2010 Go to the issue